142 related articles for article (PubMed ID: 20922266)
1. Cost-effectiveness of implantable cardioverter defibrillators in Brazil in the public and private sectors.
Ribeiro RA; Stella SF; Zimerman LI; Pimentel M; Rohde LE; Polanczyk CA
Arq Bras Cardiol; 2010 Oct; 95(5):577-86. PubMed ID: 20922266
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of implantable cardioverter-defibrillators in Brazil: primary prevention analysis in the public sector.
Ribeiro RA; Stella SF; Camey SA; Zimerman LI; Pimentel M; Rohde LE; Polanczyk CA
Value Health; 2010; 13(2):160-8. PubMed ID: 19725912
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of a microvolt T-wave alternans screening strategy for implantable cardioverter-defibrillator placement in the MADIT-II-eligible population.
Chan PS; Stein K; Chow T; Fendrick M; Bigger JT; Vijan S
J Am Coll Cardiol; 2006 Jul; 48(1):112-21. PubMed ID: 16814657
[TBL] [Abstract][Full Text] [Related]
4. [Cost effectiveness of implantable cardioverter-defibrillators for patients who are at risk for sudden death in Argentina].
Alcaraz A; González-Zuelgaray J; Augustovski F
Value Health; 2011; 14(5 Suppl 1):S33-8. PubMed ID: 21839896
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of primary prevention implantable cardioverter defibrillator treatment: data from a large clinical registry.
Thijssen J; van den Akker van Marle ME; Borleffs CJ; van Rees JB; de Bie MK; van der Velde ET; van Erven L; Schalij MJ
Pacing Clin Electrophysiol; 2014 Jan; 37(1):25-34. PubMed ID: 23998638
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of implantable cardioverter-defibrillators.
Sanders GD; Hlatky MA; Owens DK
N Engl J Med; 2005 Oct; 353(14):1471-80. PubMed ID: 16207849
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of cardiac resynchronization therapy in combination with an implantable cardioverter defibrillator (CRT-D) for the treatment of chronic heart failure from a German health care system perspective.
Aidelsburger P; Grabein K; Klauss V; Wasem J
Clin Res Cardiol; 2008 Feb; 97(2):89-97. PubMed ID: 17955159
[TBL] [Abstract][Full Text] [Related]
8. The long-term cost-effectiveness of cardiac resynchronization therapy with or without an implantable cardioverter-defibrillator.
Yao G; Freemantle N; Calvert MJ; Bryan S; Daubert JC; Cleland JG
Eur Heart J; 2007 Jan; 28(1):42-51. PubMed ID: 17110403
[TBL] [Abstract][Full Text] [Related]
9. Potential cost-effectiveness of prophylactic use of the implantable cardioverter defibrillator or amiodarone after myocardial infarction.
Sanders GD; Hlatky MA; Every NR; McDonald KM; Heidenreich PA; Parsons LS; Owens DK
Ann Intern Med; 2001 Nov; 135(10):870-83. PubMed ID: 11712877
[TBL] [Abstract][Full Text] [Related]
10. Cost-Effectiveness of Implantable Cardioverter-Defibrillators in Children with Cardiac Conditions Associated with Risk for Sudden Cardiac Death.
Haag MB; Hersh AR; Toffey DE; Sargent JA; Stecker EC; Heitner SB; Caughey AB; Balaji S
Pediatr Cardiol; 2020 Oct; 41(7):1484-1491. PubMed ID: 32623612
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of cardiac resynchronization therapy in patients with heart failure: the perspective of a middle-income country's public health system.
Bertoldi EG; Rohde LE; Zimerman LI; Pimentel M; Polanczyk CA
Int J Cardiol; 2013 Mar; 163(3):309-315. PubMed ID: 21704396
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of primary implanted cardioverter defibrillator for sudden death prevention in congestive heart failure.
Chen L; Hay JW
Cardiovasc Drugs Ther; 2004 Mar; 18(2):161-70. PubMed ID: 15162078
[TBL] [Abstract][Full Text] [Related]
13. The cost-effectiveness of primary prophylactic implantable defibrillator therapy in patients with ischaemic or non-ischaemic heart disease: a European analysis.
Smith T; Jordaens L; Theuns DA; van Dessel PF; Wilde AA; Hunink MG
Eur Heart J; 2013 Jan; 34(3):211-9. PubMed ID: 22584647
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of implantable cardioverter defibrillators in patients >or=65 years of age.
Sanders GD; Kong MH; Al-Khatib SM; Peterson ED
Am Heart J; 2010 Jul; 160(1):122-31. PubMed ID: 20598982
[TBL] [Abstract][Full Text] [Related]
15. Wearable cardioverter-defibrillator for prevention of sudden cardiac death after infected implantable cardioverter-defibrillator removal: A cost-effectiveness evaluation.
Healy CA; Carrillo RG
Heart Rhythm; 2015 Jul; 12(7):1565-73. PubMed ID: 25839113
[TBL] [Abstract][Full Text] [Related]
16. Implantable or external defibrillators for individuals at increased risk of cardiac arrest: where cost-effectiveness hits fiscal reality.
Cram P; Katz D; Vijan S; Kent DM; Langa KM; Fendrick AM
Value Health; 2006; 9(5):292-302. PubMed ID: 16961547
[TBL] [Abstract][Full Text] [Related]
17. Microvolt T-wave alternans and the selective use of implantable cardioverter defibrillators for primary prevention: a cost-effectiveness study.
Filion KB; Xie X; van der Avoort CJ; Dendukuri N; Brophy JM
Int J Technol Assess Health Care; 2009 Apr; 25(2):151-60. PubMed ID: 19331707
[TBL] [Abstract][Full Text] [Related]
18. Lifetime cost-effectiveness of prophylactic implantation of a cardioverter defibrillator in patients with reduced left ventricular systolic function: results of Markov modelling in a European population.
Cowie MR; Marshall D; Drummond M; Ferko N; Maschio M; Ekman M; de Roy L; Heidbuchel H; Verboven Y; Braunschweig F; Linde C; Boriani G
Europace; 2009 Jun; 11(6):716-26. PubMed ID: 19359333
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of implantable cardioverter-defibrillators in children with dilated cardiomyopathy.
Feingold B; Arora G; Webber SA; Smith KJ
J Card Fail; 2010 Sep; 16(9):734-41. PubMed ID: 20797597
[TBL] [Abstract][Full Text] [Related]
20. Cost effectiveness of implantable cardioverter defibrillators for 1.5 primary prevention of sudden cardiac arrest in China: an analysis from the Improve SCA study.
Sun H; Liu X; Fu J; Song Y; Qin X; Wang H
J Med Econ; 2024; 27(1):575-581. PubMed ID: 38566556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
